Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q1 2021 Earnings Conference Call May 5, 2021 5:00 PM ET Company Participants Christine Cassiano - CCO David Chang - President and CEO Rafael Amado - EVP-Research and Development and CMO Eric Schmidt - CFO Conference Call Participants Salveen Richter - Goldman Sachs Marc Frahm - Cowen & Company Kelly Shi - Jefferies Michael Schmidt - Guggenheim John Newman - Canaccord Cory Kasimov - J.P. Morgan Luca Issi - RBC Capital Mark Breidenbach - Oppenheimer Ben Burnett - Stif ...